Author(s):
MATTMAN, A. 
; HUNTSMAN, D. ; LOCKITCH, G. ; LANGLOIS, S. ; BUSKARD, N. ; RALSTON, D. ; BUTTERFIELD, Y. ; RODRIGUES, P. ; JONES, S. ; PORTO, G. ; MARRA, M. ; DE SOUSA, M. ; VATCHER, G.
Date: 2002
Persistent ID: http://hdl.handle.net/10400.16/826
Origin: Repositório Científico do Centro Hospitalar do Porto
Description
Blood. 2002 Aug 1;100(3):1075-7.
Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation.
Mattman A, Huntsman D, Lockitch G, Langlois S, Buskard N, Ralston D, Butterfield Y, Rodrigues P, Jones S, Porto G, Marra M, De Sousa M, Vatcher G.
SourceGenes, Elements, and Metabolism Program, Children and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada.
Abstract
Hereditary hemochromatosis (HH) is classically associated with a Cys282Tyr (C282Y) mutation of the HFE gene. Non-C282Y HH is a heterogeneous group accounting for 15% of HH in Northern Europe. Pathogenic mutations of the transferrin receptor 2 (TfR2) gene have been identified in 4 Italian pedigrees with the latter syndrome. The goal of this study was to perform a mutational analysis of the TfR2 and HFE genes in a cohort of non-C282Y iron overload patients of mixed ethnic backgrounds. Several sequence variants were identified within the TfR2 gene, including a homozygous missense change in exon 17, c2069 A-->C, which changes a glutamine to a proline residue at position 690. This putative mutation was found in a severely affected Portuguese man and 2 family members with the same genotype. In summary, pathologic TfR2 mutations are present outside of Italy, accounting for a small proportion of non-C282Y HH.
